Compass Therapeutics Inc. (CMPX) FY2024Q1 Earning Prediction
Compass Therapeutics Inc. (CMPX) is set to release its earnings performance on 05/13 ET in trading. Consensus forecasts predict a revenue of - and an earnings per share (EPS) of -0.11 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
CMPX Transcript
The earnings call highlights strong financial performance, with increased dividends and share repurchases, and a 10% growth in loans under management. The Q&A reveals positive sentiment, with management providing optimistic guidance on loan impairments and cost savings. Despite some vague responses on future losses, the overall tone is upbeat, supported by strategic focus on profitable loans and growth in the credit card portfolio. The combination of these factors suggests a positive stock price movement.
CMPX Report
Frequently Asked Questions
What is the Compass Therapeutics Inc. FY2024Q1 Earnings Release Date and Time?
Compass Therapeutics Inc. (CMPX) is scheduled to release its FY2024Q1 earnings report onMay 13, 2024, (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for Compass Therapeutics Inc. FY2024Q1 Revenue and EPS?
Analysts' consensus predicts in revenue and an EPS of -0.11 for Compass Therapeutics Inc.'s FY2024Q1.
What Does Intellectia's AI Predict for Compass Therapeutics Inc. FY2024Q1 Earnings?
Intellectia's exclusive AI algorithms forecast a forCompass Therapeutics Inc.'s FY2024Q1 earnings, with a prediction date of May 13, 2024. Compass Therapeutics Inc.
How Can I Use This Earnings Prediction to Trade CMPX Stock?
Leverage Intellectia's AI forecast to position trades ahead of theMay 13, 2024 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like Compass Therapeutics Inc. FY2024Q1?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
